PMEL and renal cell carcinoma: The expression of Melan-A and HMB45 was significantly lower in TFE3-rearranged renal cell carcinoma compared with TFEB-rearranged renal cell carcinoma, even when a 5% cutoff was used (17% and 27% respectively).